T1	intervention 10 33	Dietary Flaxseed Intake
T2	No-of-participants 494 496	99
T3	eligibility 74 94	Postmenopausal Women
T4	eligibility 497 517	postmenopausal women
T5	location 521 536	Toronto, Canada
T6	control 631 642	control arm
T7	control 654 664	usual diet
T8	duration 618 625	7 weeks
T9	outcome-Measure 666 725	Baseline and week 7 concentrations of 14 serum sex hormones
T10	outcome-Measure 825 863	serum enterolignans (lignan biomarker)
T11	outcome 967 996	Serum enterolignans increased
T12	outcome 1083 1105	serum 2-hydroxyestrone
T13	outcome 1167 1193	2:16Î±-hydroxyestrone ratio
T14	outcome 1313 1341	change in enterolignan level
